DZDonglei Zhang

Donglei Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Donglei Zhang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients

    by Lin Luo, Xiaoyan Liu, Hui Shen, Hao Zhang, Yufeng Shang, Xian Zhang, Donglei Zhang

    Background: Essential thrombocythemia (ET) is one of the Philadelphia-negative (Ph−) classical myeloproliferative neoplasms (MPNs), characterized by increased megakaryocyte and platelet counts, as well as an increased risk of thrombo-hemorrhagic complications. The JAK2 V617F mutation is detected in 50%–60% of patients with ET and can drive ET occurrence through ligand-independent activation of the thrombopoietin (TPO) receptor, resulting in JAK/STAT pathway signaling. Phosphatase and tensin homolog (PTEN) has been found to be associated with many hematologic diseases, particularly in MPNs, and is involved in the JAK/STAT pathway. This study aimed to determine the role of PTEN in ET patients with the JAK2 V617F mutation.Methods: In this study, we analyzed a series of 32 ET patients without treatment and 25 age- and sex-matched normal controls for the detection of PTEN expression and the STT motif phosphorylation of PTEN, as well as the expression patterns of STAT3 and STAT5 and their phosphorylated molecules (p-STAT3 and p-STAT5, respectively), in bone marrow mononuclear cells (BM-MNCs) by immunohistochemical (IHC) staining of bone marrow biopsies and Western blotting. Correlations between the PTEN expression and other clinical characteristics were also examined.Results: The results showed a downregulated PTEN expression in the BM-MNCs of patients with ET, as well as an elevated p-STAT3 expression and a decreased p-STAT5 expression. In addition, analysis in combination with clinical data demonstrated a negative correlation between the expression of PTEN and the patients’ age and platelet counts. In contrast, a positive correlation was detected between the expression of PTEN and the level of p-STAT5.Conclusions: The results of this study suggest that aberrant PTEN expression and JAK/STAT pathway signaling might be involved in the onset of ET. Our findings could shed new light on the pathogenesis of and the treatment for ET.

  • Declined presentation the effects of interferon α-2b on defective bone marrow mesenchymal stem cells in patients with essential thrombocythemia

    by Tiantian Sun, Cuicui Lv, Donglei Zhang, Mingen Lv, Xian Zhang, Wenjie Liu, Rongfeng Fu, Huiyuan Li, Feng Xue, Xiaofan Liu, et al.

    • 14 August 2015
      • p. 1-11

    Abnormal lipid rafts related ganglioside expression and signaling in T lymphocytes in immune thrombocytopenia patients.

    by Xian Zhang, Donglei Zhang, Wenjie Liu, Huiyuan Li, Rongfeng Fu, Xiaofan Liu, Feng Xue, Renchi Yang

    Aberrant T lymphocytes signaling is considered to play a crucial role in the abnormal immune state of primary immune thrombocytopenia (ITP). Lipid raft has been verified to engage in the T cell receptor (TCR)-mediated T lymphocytes signal transduction. Whether lipid raft-associated T cells signal transduction has impact on the pathogenesis of ITP is still unconfirmed. In this study, we aimed to reveal the abnormality in structure and function of lipid rafts (LRs) in CD4+ and CD8+ T lymphocytes of patients with ITP. Our results showed that there was an increased lipid raft aggregation in ITP patients, while this kind of increase would not be influenced by platelet counts or therapeutic regimes. Stimulation by anti-CD3/CD28 monoclonal antibodies promoted enhanced lipid raft clustering in T lymphocytes of ITP patients compared with negative controls. Methyl-β-cyclodextrin (MβCD) could block the abnormal lipid raft aggregation and disrupt the TCR-mediated T cells proliferation and cytokines secretion, including both proinflammatory cytokines and anti-inflammatory cytokines. The spontaneous activation of T lymphocytes from ITP patients might be due to the elevated co-localization of protein tyrosine phosphatase (PTP) CD45 and lipid rafts in patients' CD4+ and CD8+ T lymphocytes. These findings suggest that the autoactivation of T lymphocytes from ITP patients may lead to the abnormality in lipid raft structure and raft-anchored proteins, and the changes conversely promote the TCR-mediated T cells activation of ITP patients.

  • The polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese population

    by Hu Zhou, Jingyi Yang, Liu Liu, Donglei Zhang, Keshu Zhou, Huiyuan Li, Huifang Zhao, Lijie Han, Jian Zhou, Xinjian Liu, et al.

    Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by decrease of the platelet count and increased risk of mucocutaneous bleeding. Multiple factors have been demonstrated in ITP pathogenesis, including the genetic variants. Tumor necrosis factor-induced protein 3 (TNFAIP3) gene encodes the ubiquitin-modifying enzyme A20 which limits inflammation by terminating NF-κB activation through several signaling pathways including TNF and Toll-like receptors and regulates immunostimulatory effects of dendritic cells and attenuates antigen presentation. Single nucleotide polymorphisms (SNPs) of TNFAIP3 have been associated with susceptibilities to several autoimmune diseases. Therefore, we speculated that TNFAIP3 polymorphisms might be associated with the susceptibility of chronic ITP in Chinese population. We investigated the distribution of TNFAIP3 (rs2230926 and rs5029939) polymorphisms in 222 patients with chronic ITP and 153 controls by polymerase chain reaction–restriction fragment length polymorphism and direct sequencing. We observed significant difference in the allelic and genotypic distributions of rs2230926 and rs5029939 between the ITP and control groups (p < 0.05). Stratified analysis by gender revealed the association of rs2230926 polymorphism with chronic ITP in male groups. However, none of the two polymorphisms contributed to the onset age of chronic ITP. These data suggest an association of TNFAIP3 SNPs with susceptibility to chronic ITP. Together with previous reports, our finding provides further evidence for TNFAIP3 being a general autoimmunity gene.


  • [Clinical characteristics and risk factors for major thrombosis in 604 Chinese patients with low-risk essential thrombocythemia].

    by Rongfeng Fu, Min Xuan, Liyan Zhang, Huiyuan Li, Tiantian Sun, Donglei Zhang, Xian Zhang, Cuicui Lyu, Feng Xue, Xiaofan Liu, et al.

    To analyze clinical and molecular characteristics of low-risk essential thrombocythemia (ET) in a large cohort of Chinese patients and to explore risk factors for major thrombosis and treatment strategies. Medical records of patients with an initial diagnosis of ET from March 1982 to May 2012 in our hospital were retrospectively analyzed. A total of 604 low-risk ET patients were enrolled with a median follow-up of 49 months (range:0-338). 43(7.1%) patients experienced major thrombotic events. Cox proportional hazards regression revealed JAK2 V617F mutation (HR=2.279; P=0.035) and cardiovascular risk factors (CVF) (HR=2.541; P=0.006) to be risk factors for total thrombotic events, while only CVF (HR=2.633; P=0.008) was risk factor for arterial thrombosis. None of the evaluated factors was related to venous thrombosis. Patients with both JAK2 V617F mutation and CVF had a worse thrombosis- free survival than those with only one risk factor (P<0.05). In patients with JAK2 V617F or CVF alone, antiplatelet treatment (P=0.016) significantly decreased the risk of thrombosis, while those with both JAK2 V617F and CVF could benefit from cytoreductive agents (P=0.018). Chinese low-risk ET patients have a lower risk of thrombosis than Caucasian low-risk ET patients. JAK2 V617F mutation and CVF are the most significant risk factors for thrombosis. Existence of both risk factors further increases the thrombotic risk. Treatment strategies on low-risk ET patients should be made based on presence or absence of risk factors.


  • [Role of Toll-like receptor 2 in primary immune thrombocytopenia].

    by Hui-Yuan Li, Dong-Lei Zhang, Xian Zhang, Rong-Feng Fu, Min Xuan, Ren-Chi Yang

    The aim of this study was to explore the role of Toll-like receptor (TLR) 2 in primary immune thrombocytopenia (ITP) by detecting TLR2 expression in the peripheral blood lymphocytes of patients with ITP and evaluating the role of TLR2 activation on inflammatory cytokine secretion. A total of 39 ITP patients and 21 normal controls were enrolled in this study. The expression of TLR2 was detected by real-time PCR and flow cytometry, and the concentration of IL-6 and TNF-α in culture supernatant of PBMNC treated with pam3CSK4 for 48 hours were detected by ELISA. The results showed that the expression of TLR2 mRNA in active ITP patients (3.561 ± 0.741) was significantly higher than that in normal controls (1.750 ± 0.314) (P < 0.05), but there was no statistically significant difference between remission ITP patients (2.333 ± 0.448) and normal controls (P > 0.05) . Flow cytometry analysis found that the TLR2 was not expressed on T and B cells, but expressed on all monocytes both from ITP patients and normal controls. Further activation experiment showed that TLR2 activation in vitro could induce the expression of IL-6 (1644 ± 634.0 vs 4111 ± 525.2 pg/ml) and TNF-α (75.37 ± 22.31 vs 326.0 ± 109.9 pg/ml) in PBMNC from ITP patients (both P < 0.05), but just could promote IL-6 expression in normal controls (2119 ± 636.9 vs 4671 ± 315.9 pg/ml)(P < 0.05). It is concluded that the expression of TLR2 mRNA is up-regulated in PBMNC of ITP patients, and this increased TLR2 maybe participate in ITP through inducing secretion of inflammatory cytokines.


  • Increased expressions of DNA methyltransferases contribute to CD70 promoter hypomethylation and over expression of CD70 in ITP

    by Li Ma, Zeping Zhou, Hongmei Wang, Hu Zhou, Donglei Zhang, Huiyuan Li, Aiping Qi, Renchi Yang